Improving the use of medications in children
BPCA - IMPROVING OFF-LABEL MEDICATION USE IN CHILDREN (OLMU)
This study is all about making sure that kids aged 0-11 get the right medications that work safely for them, by learning more about how their bodies handle these drugs and how they affect their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10706857 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding and safe use of medications in children, particularly those aged 0-11 years. It aims to address gaps in knowledge regarding how children's bodies process drugs and the effects of these medications on their health. By bridging pharmacokinetic data with clinical outcomes, the research seeks to ensure that pediatric patients receive personalized and effective treatments. The study involves collaboration among various stakeholders, including the FDA and NIH, to improve drug development for children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who may require medications that are currently used off-label.
Not a fit: Patients who are older than 11 years or those who do not require medication may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medication use in children, reducing the risks associated with off-label drug use.
How similar studies have performed: Previous research has shown success in improving pediatric medication use through similar collaborative approaches, indicating a promising path forward.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Greenberg, Rachel — Duke University
- Study coordinator: Greenberg, Rachel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.